Investment25 Nov 2024, 07:31 pm
Strides Pharma Science's Associate Company, OneSource, Secures USD 95 Million in Funding at a Pre-Money Valuation of USD 1.65 Billion
AI Summary
Strides Pharma Science Ltd. has announced the successful completion of a fundraising activity by its associate company, OneSource Specialty Pharma Limited. OneSource has raised USD 95 Million from marquee domestic and international investors, including HBM Healthcare Investments, WhiteOak Capital, Param Capital, Motilal Oswal, Enam Holdings, SBI Life Insurance Co Ltd, and Valuequest Investment Advisors. The fundraising involved the issuance of 6,277,909 equity shares at a price of INR 1,276 per share, with a pre-money equity valuation of USD 1.65 billion. This milestone reinforces OneSource's strong positioning as India's first specialty pharma CDMO and its readiness for robust growth ahead of its proposed listing.
Key Highlights
- OneSource has successfully raised USD 95 Million from marquee investors.
- The fundraising involved the issuance of 6,277,909 equity shares at a price of INR 1,276 per share.
- The pre-money equity valuation of OneSource stands at USD 1.65 billion.
- The fundraising was led by HBM Healthcare Investments and associated investors.
- This milestone reinforces OneSource’s strong positioning as India’s first specialty pharma CDMO.